Newsbenzinga
If You Invested $100 In Cytokinetics Stock 10 Years Ago, You Would Have This Much Today
· Published
Article summary
Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 7.78% on an annualized basis producing an average annual return of 21.28%. Currently, Cytokinetics has a market capitalization of $10.34
An excerpt from the original article.
Comments —
Loading comments…